Results 271 to 280 of about 25,148 (309)
Some of the next articles are maybe not open access.

Sclerostin Deficiency Promotes Reparative Dentinogenesis

Journal of Dental Research, 2017
In humans, the SOST gene encodes sclerostin, an inhibitor of bone growth and remodeling, which also negatively regulates the bone repair process. Sclerostin has also been implicated in tooth formation, but its potential role in pulp healing remains unknown.
Collignon, A.-M.   +10 more
openaire   +3 more sources

Sclerostin in Periodontal Ligament: Homeostatic Regulator in Biophysical Force-Induced Tooth Movement.

Journal of Clinical Periodontology, 2022
AIM This study elucidates the role of sclerostin in periodontal ligament (PDL) as a homeostatic regulator in biophysical force-induced tooth movement (BFTM).
Yoo-Sung Nam   +9 more
semanticscholar   +1 more source

Interactions between Sclerostin and Glycosaminoglycans

Glycoconjugate Journal, 2019
Sclerostin (SOST) is a glycoprotein having many important functions in the regulation of bone formation as a key negative regulator of Wnt signaling in bone. Surface plasmon resonance (SPR), which allows for a direct quantitative analysis of the label-free molecular interactions in real-time, has been widely used for the biophysical characterization of
Fuming Zhang   +3 more
openaire   +2 more sources

Sclerostin in Obstructive Sleep Apnea

2015
Sclerostin, a glycoprotein involved in vascular calcification, could play a role in cardiovascular disorders. Obstructive sleep apnea (OSA) is frequently associated with cardiovascular comorbidities. Thus, in this study we set out to assess the level of sclerostin in patients with OSA.
M, Kosacka, I, Porębska, A, Brzecka
openaire   +3 more sources

Sclerostin and CKD-MBD

Current Osteoporosis Reports, 2015
Declining kidney function is associated with sequential systemic changes in mineral homeostasis leading to pathologic alterations in the cardiovascular system and the skeleton. One of the earliest changes in response to renal injury is the increased osteocyte production of secreted factors including the anti-anabolic protein, sclerostin.
openaire   +2 more sources

Sclerostin and DKK1 in Primary Hyperparathyroidism

Calcified Tissue International, 2013
Bone formation is influenced by the Wnt pathway through effects on osteoblast functionality, and these actions are opposed by two antagonists: sclerostin and Dickkopf-1 (DKK1). Decreased levels of serum sclerostin were found after treatment with the PTH analogue teriparatide and in patients with primary hyperparathyroidism (PHPT), while treatment with ...
VIAPIANA, Ombretta   +6 more
openaire   +2 more sources

Sclerostin and Adipose Tissue

Current Molecular Biology Reports, 2017
Since its discovery 15 years ago, inhibition of sclerostin has come to be identified as a potent anabolic agent. The sclerostin neutralizing antibody, romosozumab, is a promising treatment for postmenopausal osteoporosis. Animal studies also show a role of sclerostin in regulating hematopoietic cells and, more recently, adipocytes.
Keertik Fulzele, Paola Divieti Pajevic
openaire   +1 more source

New Emerging Biomarkers for Bone Disease: Sclerostin and Dickkopf-1 (DKK1)

Calcified Tissue International, 2022
Aylin Sepinci Dincel, N. Jørgensen
semanticscholar   +1 more source

Sclerostin Inhibition

2021
Cristiana Cipriani, John P. Bilezikian
openaire   +1 more source

Beyond Sclerostin

Medicine & Science in Sports & Exercise, 2016
Corinne E. Metzger   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy